| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/09/1995 | EP0666080A1 Treatment of autoimmune diseases by oral administration of autoantigens |
| 08/09/1995 | EP0666034A1 Process for preparing fractionated soybean proteins and foods using the same |
| 08/09/1995 | EP0665888A1 Ryegrass pollen allergen |
| 08/09/1995 | EP0665852A1 Recombinant ctla4 polypeptides and methods for making the same |
| 08/09/1995 | EP0665842A1 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 08/09/1995 | EP0665753A1 Fludarabine-5'-monophosphate for the treatment of autoimmune diseases |
| 08/09/1995 | EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 08/09/1995 | EP0535152B1 Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylene and piperazine compounds as PAF antagonists and compositions thereof. |
| 08/09/1995 | EP0348446B1 Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides |
| 08/09/1995 | CN1106296A Nutritional Supplement |
| 08/08/1995 | US5440035 Leukotriene antagonists; antiallergens, antiinflammatory agents |
| 08/08/1995 | US5440017 T-cell lymphoma cDNA clones |
| 08/08/1995 | US5439929 Bicyclic carbamates, pharmaceutical compositions and use |
| 08/08/1995 | US5439895 4-aminoquinazoline derivatives |
| 08/08/1995 | CA1336605C Indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 08/08/1995 | CA1336581C Aloe composition and uses thereof |
| 08/04/1995 | CA2141729A1 N-(3-aminopropyl)-n-phenyl-5,6,7,8-tetrahydro-naphthalene -2-carboxamide derivatives, their preparation and their therapeutic use |
| 08/03/1995 | WO1995020660A2 Immunization by inoculation of dna transcription unit |
| 08/03/1995 | WO1995020655A1 Novel cell surface receptor, antibody compositions, and methods of using same |
| 08/03/1995 | WO1995020605A1 Immuno-stimulatory monoclonal antibodies |
| 08/03/1995 | WO1995020599A1 B cell epitope of mite allergen |
| 08/03/1995 | WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
| 08/03/1995 | WO1995020575A1 Aralkylamino substituted azacyclic therapeutic agents |
| 08/03/1995 | WO1995020563A1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs |
| 08/03/1995 | WO1995020395A1 Atopic disease remedy |
| 08/03/1995 | WO1995020393A1 Use of mometasone furoate for treating airway passage and lung diseases |
| 08/03/1995 | WO1995020390A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation |
| 08/03/1995 | CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents |
| 08/03/1995 | CA2180443A1 Novel cell surface receptor, antibody compositions, and methods of using same |
| 08/03/1995 | CA2179715A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation |
| 08/02/1995 | EP0665289A2 Peptides from GAD65, provoking autoimmune reactions |
| 08/02/1995 | EP0665013A1 Method of treating hyperproliferative vascular disease |
| 08/02/1995 | EP0665012A1 Antiallergy agent and nutritional composition containing glutamine and process for the production thereof |
| 08/02/1995 | EP0664780A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
| 08/02/1995 | EP0664700A1 Treatment of cachexia and inhibition of il-6 activity |
| 08/02/1995 | CN1105991A Quinoline compounds |
| 08/02/1995 | CN1105867A High-efficacy compound drug for treatment of rheumatism |
| 08/01/1995 | US5438141 Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists |
| 08/01/1995 | CA1336516C Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines |
| 07/27/1995 | WO1995019978A1 Tetracyclic derivatives, process of preparation and use |
| 07/27/1995 | WO1995019961A1 Metalloproteinase inhibitors |
| 07/27/1995 | WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 07/27/1995 | WO1995019957A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 07/27/1995 | WO1995019956A1 Metalloproteinase inhibitors |
| 07/27/1995 | WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
| 07/27/1995 | WO1995019786A1 Use of interleukin-12 to prevent graft versus host disease |
| 07/27/1995 | WO1995019784A1 Human therapeutic uses of bpi protein products |
| 07/27/1995 | WO1995019777A2 Use of diesters of muramyl peptides in oral form as immunostimulating agents |
| 07/27/1995 | WO1995012677A3 Immunodominant human t-cell epitopes of hepatitis c virus |
| 07/27/1995 | CA2181899A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents |
| 07/27/1995 | CA2181816A1 Human therapeutic uses of bpi protein products |
| 07/27/1995 | CA2181709A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 07/27/1995 | CA2126361A1 Gene encoding cationic amino acid transporter protein |
| 07/26/1995 | EP0664289A2 Isoquinolines |
| 07/26/1995 | EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives |
| 07/26/1995 | EP0664125A1 Inhibition of myeloperoxidase activity |
| 07/26/1995 | EP0664123A1 Inhibition of autoimmune diseases |
| 07/26/1995 | EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 07/26/1995 | EP0663902A1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
| 07/26/1995 | EP0663828A1 Compositions for treating allergic disorders using (-) cetirizine |
| 07/25/1995 | US5436262 Pharmacologically active derivatives of 2-(benzimidazol-2-yl)-1,3-diaminopropane |
| 07/25/1995 | US5436234 Eurcyl, brassidyl and nervonyl derivatives |
| 07/25/1995 | US5436233 Nervous system disorders |
| 07/25/1995 | US5436231 Hypertensive agents |
| 07/25/1995 | US5436162 Human manganese superoxide dismutase (hMn-SOD) |
| 07/25/1995 | US5436154 Stable hybridoma cells and antigen-antibodies |
| 07/25/1995 | CA1336431C Thiazolo(5,4-b)azepine compounds |
| 07/25/1995 | CA1336399C Adjuvant for cancer immunotherapy |
| 07/25/1995 | CA1336397C Methyl cellulose pharmaceutical composition |
| 07/21/1995 | CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use |
| 07/20/1995 | WO1995019435A2 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor |
| 07/20/1995 | WO1995019375A1 Peptides and methods against psoriasis |
| 07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/20/1995 | WO1995019362A1 Dihydro pyrazolopyrroles |
| 07/20/1995 | WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/20/1995 | WO1995019181A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |
| 07/20/1995 | WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/20/1995 | CA2181171A1 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/20/1995 | CA2179280A1 Peptides and methods against psoriasis |
| 07/19/1995 | EP0663393A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors |
| 07/19/1995 | EP0663008A1 Improvements in or relating to immune response modification |
| 07/19/1995 | EP0662834A1 Novel epoxide-containing compounds |
| 07/19/1995 | EP0662782A1 Pp14-based therapy |
| 07/19/1995 | CN1105367A Glucosamine derivative, process for preparing the same and synthetic intermediate thereof |
| 07/18/1995 | US5434245 Osteocalcin |
| 07/18/1995 | US5434186 Antiinflammatory agents |
| 07/18/1995 | US5434183 Phospholipids containing omega-3-fatty acids |
| 07/18/1995 | US5434163 Treatment of Cryptococcus neoformans infection |
| 07/18/1995 | US5434160 Autoimmune diseases; prevention of excess cell proliferation or enzyme release |
| 07/18/1995 | US5434158 Asthma |
| 07/18/1995 | US5434151 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| 07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use |
| 07/18/1995 | US5433948 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 07/18/1995 | CA1336349C Nitrogenous polycyclic tripeptides, their preparation and pharmaceutical compositions containing them |
| 07/18/1995 | CA1336322C Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors |
| 07/13/1995 | WO1995018863A1 Composition containing nucleic acids, preparation and uses |
| 07/13/1995 | WO1995018856A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 07/13/1995 | WO1995018854A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |